Yu-Jie Bao

909 citations
15 papers · 323 indexed · h-index 6
Topics
SARS-CoV-2 and COVID-19 Research (2 papers)COVID-19 Clinical Research Studies (2 papers)Long-Term Effects of COVID-19 (2 papers)
Partner nations
ChinaMalaysiaIndonesia

In The Last Decade

Yu-Jie Bao

13 papers receiving 320 citations

Peers

Yu-Jie Bao
Comparison fields: 5 of 85
  • Molecular Biology 212
  • Epidemiology 60
  • Cancer Research 56
  • Infectious Diseases 55
  • Biomedical Engineering 38
Replace Ning‐Ning Liu with:
Ning‐Ning Liu China
Nobuko Kojima Japan
Zari Naderi Ghale-Noie Iran
Xin Yin China
Luca Di Martino United States
Bo Jin China
Caio Perez Gomes Brazil
Weiwei Ge China
Yu-Jie Bao relative to Ning‐Ning Liu China Ning‐Ning Liu's profile →
Citations per field
00.5×2.9×
Ning‐Ning Liu · 1×
Citations per year

Countries citing papers authored by Yu-Jie Bao

Since Specialization
Citations

This map shows the geographic impact of Yu-Jie Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Jie Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Jie Bao more than expected).

Fields of papers citing papers by Yu-Jie Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Jie Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Jie Bao. The network helps show where Yu-Jie Bao may publish in the future.

Co-authorship network of co-authors of Yu-Jie Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Jie Bao. A scholar is included among the top collaborators of Yu-Jie Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Jie Bao. Yu-Jie Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 3
5 3
6 2
7 6
8 69
9
Retrospective study of characteristics and management of pyogenic liver abscess during 5 years' experience.
5
10 21
11 62
12 145
13 1
14
Ecological compensation of development right of water source areas
2
15 1

About Yu-Jie Bao

Yu-Jie Bao is a scholar working on Business and International Management, Infectious Diseases and Neurology, having authored 15 papers that have together received 323 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (33 citations), Cancer Research (56 citations) and Molecular Biology (212 citations). Yu-Jie Bao has collaborated with scholars based in China, Malaysia and Indonesia. Frequent co-authors include Huimin Chen, Haoyan Chen, Danfeng Sun, Jing‐Yuan Fang, Yingxuan Chen, Jie Hong, Jia‐Yin Tang, Tiantian Sun, Ming Zhong and Yun Qian. Their work appears in journals such as Cell Reports, Vaccine and Osteoporosis International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026